Evidence
Document this CPD
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Medicines Discovery Catapult: Advancing UK Medicines Discovery through Innovative Partnerships
🌐 90 Days
VR Related Evidence Matrix
- Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease
- ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines
- Modernity, Disenchantment, and the Mediaeval Discovery of Nature.
- MolProphet: A One-Stop, General Purpose, and AI-Based Platform for the Early Stages of Drug Discovery
- Mental health-related service and medicine use among a cohort of urban Aboriginal children and young people: Data linkage study
- Psychosocial Factors and Glycemic Control in Young Adults With Youth-Onset Type 2 Diabetes
- Correction: Endophenotype trait domains for advancing gene discovery in autism spectrum disorder
- Digital Scholarship coffee morning
- ORA collection on AI & Machine Learning launch event
- Sara Ahmed - Changing Institutions: Common Sense, Complaint and Other Lessons in Legacy
- : Identifying Covid-19 risk factors with simultaneous Bayesian-frequentist model-averaged hypothesis testing
- Bioinformatic Prohormone Discovery in Basal Metazoans: Insights from Trichoplax
- Emerging opportunities of using large language models for translation between drug molecules and indications
- How can multi-stakeholder partnerships support refugees and migrants with irregular status in African intermediary cities?
- Changing landscape in the field of paraneoplastic neurology: Personal perspectives over a 35-year career
- Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
- HydrogelFinder: A Foundation Model for Efficient Self-Assembling Peptide Discovery Guided by Non-Peptidal Small Molecules
- Enhancing drug discovery in schizophrenia: a deep learning approach for accurate drug-target interaction prediction - DrugSchizoNet
- Enhancing drug discovery in schizophrenia: a deep learning approach for accurate drug-target interaction prediction - DrugSchizoNet
- Digital Scholarship coffee morning
- "Linking smartphone, wearable and medical device data with routinely collected NHS data for the research community"
- Trends in exposure to drugs and prohibited substances among sports: A nationwide analysis of 2008-2022 inquiry records
- Longitudinal assessment of interstitial lung abnormalities on CT in patients with COPD using artificial intelligence-based segmentation: a prospective observational study
- Listening Sessions to Shape the Innovative NIH ComPASS Common Fund Program to Advance Health Equity
- Primordial Origins of RNA Therapeutics
- MFTrans: A multi-feature transformer network for protein secondary structure prediction
- DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery
- Peptide-derived ligands for the discovery of safer opioid analgesics
- Managing social-educational robotics for students with autism spectrum disorder through business model canvas and customer discovery
- AI-generated food images look tastier than real ones
- Tribulations and future opportunities for artificial intelligence in precision medicine
- Listening to life: Sonification for enhancing discovery in biological research
- Listening to life: Sonification for enhancing discovery in biological research
- Autonomous Synthesis of Thin Film Materials with Pulsed Laser Deposition Enabled by In Situ Spectroscopy and Automation
- Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies
- Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review
- Development and Validation of a Machine Learning-Based Model of Mortality Risk in First-Episode Psychosis
- Discovery of Potent Multikinase Type-II Inhibitors Targeting CDK5 in the DFG-out Inactive State with Promising Potential against Glioblastoma
- The power of many brains: Catalyzing neuropsychiatric discovery through open neuroimaging data and large-scale collaboration
- An Introduction to Policy Engagement for Historians
- Yeast Platforms for Production and Screening of Bioactive Derivatives of Rauwolscine
- Yeast Platforms for Production and Screening of Bioactive Derivatives of Rauwolscine
- Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application
- The Pandemic EVIDENCE Collaboration
- Multiscale topology in interactomic network: from transcriptome to antiaddiction drug repurposing
- Artificial Intelligence (AI) and Alternative Variables (AV) in Drug Discovery: A Promising Alliance
- Unsupervised deep representation learning enables phenotype discovery for genetic association studies of brain imaging
- Lessons into lupus pathogenesis from inborn errors of immunity
- Film Screening followed by Q&A with the Director: "Stepping Softly on the Earth", by Marcos Colón
- A brain structural connectivity biomarker for autism spectrum disorder diagnosis in early childhood
- CVs for non-academic roles
- “In and Out of Context: Deciphering the Genetic and Genomic Architecture of Type 2 Diabetes”
- Preventable suicides involving medicines: A systematic case series of coroners' reports in England and Wales
- Open scholarship: introduction to open science framework at Oxford
- Reported quality indicators and implementation outcomes of community partnership in autism intervention research: A systematic review
- Feminist Thinking Seminar Series: Anti-Black Ontologies of the ‘Human’ as a Problem
- Spotl:ght: Illuminating Engineering
- Innovative applications of artificial intelligence during the COVID-19 pandemic
- Rachel Edwards: Prevention of future deaths report
- Rachel Edwards: Prevention of future deaths report
- First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging
- Shakespeare Schools at Magdalen
- New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites
- 2-Day Conference - Oxford Medieval Graduate Conference 2024: Signs and Scripts
Evidence Blueprint
Medicines Discovery Catapult: Advancing UK Medicines Discovery through Innovative Partnerships
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Medicines Discovery Catapult: Advancing UK Medicines Discovery through Innovative Partnerships
🌐 365 Days
VR Related Evidence Matrix
- Genetics and Drug discovery
- iSkills: Data sources for research - discovery, access and use
- The discovery of Paxlovid- the journey of the Pfizer SARS2-Covid 19 drug
- Towards Precision Psychiatry: CNS Discovery Research at Boehringer Ingelheim
- Pre-clinical modelling for drug discovery in amyotrophic lateral sclerosis
- AI genomics for target discovery and other applications
- Therapeutic target discovery in complex neuron-astrocyte stem cell models of Parkinson’s
- 23 & 24 July 2023 - Save Ancient Studies Alliance (SASA) Virtual Conference 2023: Discovery, Science, and Technology in the Anci...
- Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease
- Open scholarship: playing in the open: getting familiar with creative commons licences
- THIS EVENT HAS BEEN POSTPONED AND WILL BE REARRANGED FOR LATER IN THE YEAR Mitochondria at neuronal synapses: why are they there...
- History research event and lunch in memory of Dr John Walsh
- "Business for researchers" panel event and networking lunch (in-person / IDRM building)
- Open Scholarship: Forum of Open Scholarship
- Open Science
- Open Scholarship: Copyright the Card Game
- Oxford Parkinson’s Disease Centre (OPDC) Open Day
- Hertford Festival Talks Programme
- Kampo Medicines Used in Psychiatry
- WHG Lunchtime Lab Talks: Ralser and Zhang Groups
- WHG Lunchtime Lab Talks: Church and Grimes Groups
- Leukocyte Compartmentalisation and metabolism in secondary lymphoid tissues (two talks)
- Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
- WHG Lunchtime Lab Talks: Hinch and Mentzer-Hill Groups
- WHG Lunchtime Lab Talks: Bonsall & Choudhury Groups
- Old English Work in Progress: ‘“I will open my mouth in parables”: A new biblical context for early medieval English riddles’
- TBC
- Icons: a Way of Truly Seeing
- Mutate Everything
- TBA
- Tatiana Petrova
- Atlantic Imaging
- Facilitated Networking
- Connecting with Industry
- Science in the Park
- Climate Change
- How does CD45 signal?
- What’s in a (performance) number? And how do we use it?
- Temporary post
- Evolution of the cytoskeleton
- A conversation with the Vice Chancellor
- First Year Research Students
- Plastid Preview 2023
- 40 years of conservation in Sabah
- 'Epigenetic memory through dormancy’
- The Grounds of Affirmative Action
- Iron Regulates Immunity
- New Frontiers for Prevention Psychiatry
- The strain on scientific publishing
- How to use satire to disrupt corruption
- Intracranial venous stenting
- The Hat: an aperiodic monotile
- Digital Camp for Girls
- Chromatin regulation in cancer
- SME online 1:1 sessions
- Coaching Skills for Leaders
- Biophysics Seminar MT4
- WIMM Day 2023
- TGU Christmas Quiz
- Individuality in the Work of Plotinus
- SoGE Impact Day
- New therapeutic approaches to tuberculosis
- Title to be confirmed shortly
- Global Surgery Course 2023